Moringa oleifera supplementation for anemic pregnant women: A Systematic Review and Meta-analysis
DOI:
https://doi.org/10.3329/bjms.v23i3.75014Keywords:
anemia; folic acid, iron; Moringa oleifera; pregnant PROSPERO registration number: CRD42022304292Abstract
Objective: Iron supplements are often suggested to anemic pregnant women during antenatal care. Moringa oleifera (Moringa) is rich in essential nutrients and commonly used as an alternative supplement to overcome anemia in pregnancy. There is sparse evidence of its efficacy as an anemia treatment. Thus, this systematic review and meta-analysis aimed to assess the effectiveness of Moringa’s supplementation for anemic pregnant women.
Materials and Methods: We searched the Cochrane Central Register of Controlled Trials, MEDLINE, and Epistemonikos for all randomized controlled trials (RCTs) reporting anemic pregnant ladies receiving Moringa. We independently screened the titles and abstracts of identified trials before the full text of relevant trials were evaluated for eligibility. We then independently extracted data on the methods, interventions, outcomes, and risk of bias from the included trials. Primary outcome measures were hemoglobin level and erythrocyte index levels while secondary outcomes were hematocrit level, ferritin level, and baby’s weight.
Results and Discussion: Fifteen trials with a total of 808 anemic pregnant women were analyzed using two comparisons. Moringa had increased hemoglobin level (MD 0.42, 95% CI 0.14 to 0.71; I statistic = 78%) when used 2 as an adjunct to standard treatment as well as when it was used alone (MD 0.65, 95%CI 0.40 to 0.90; I statistic = 0%; p < 0.05). 2 Furthermore, Moringa has increased MCH level (MD 0.84, 95%CI 0.11 to 1.56; I statistic = 0%; p = 0.02) and ferritin level (MD 2 18.80, 95%CI 7.53 to 30.07; p = 0.001) when used as an adjunct to standard treatment. However, it does not affect the MCV (p = 0.52), MCHC (p = 0.15), and hematocrit l (p = 0.88) for both comparisons. Conclusion. Moringa may increase hemoglobin levels when used in anemic pregnant women either as an adjunct therapy or alternative therapy to iron supplements, with no severe adverse event that could disrupt the intervention. Nevertheless, further research is needed to determine Moringa’s precise dose and ideal preparation that will impact hemoglobin levels.
Bangladesh Journal of Medical Science Vol. 23 No. 03 July’24 Page : 597-609
Downloads
46
47
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Ermadina Mohamad Kalam, Norhayati Mohd Noor, Azlina Ishak, Siti Suhaila Mohd Yusoff
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:
- Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.
Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.- Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.
